Skip to main content

Halozyme Therapeutic (NQ: HALO )

58.61 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2024 Add to My Watchlist

Other Filings

Form 3/A
Source: SEC/Edgar
February 10, 2005
Form 3/A
Source: SEC/Edgar
February 10, 2005
Form PRE 14C
Source: SEC/Edgar
February 09, 2005
Form POS AM
Source: SEC/Edgar
February 07, 2005
Form 8-K/A
Source: SEC/Edgar
February 03, 2005
Form 8-K
Source: SEC/Edgar
February 03, 2005
Form 8-K
Source: SEC/Edgar
January 31, 2005
Form 8-K
Source: SEC/Edgar
January 27, 2005
Form 144
Source: SEC/Edgar
January 20, 2005
Form SC 13G/A
Source: SEC/Edgar
January 18, 2005
Form 8-K
Source: SEC/Edgar
January 06, 2005
Form 8-K
Source: SEC/Edgar
December 13, 2004
Form 8-K
Source: SEC/Edgar
December 12, 2004
Form 424B3
Source: SEC/Edgar
November 29, 2004
Form 10QSB
Source: SEC/Edgar
November 14, 2004
Form 8-K
Source: SEC/Edgar
November 11, 2004
Form 8-K
Source: SEC/Edgar
November 11, 2004
Form S-3
Source: SEC/Edgar
November 11, 2004
Form 8-K
Source: SEC/Edgar
November 11, 2004
Form 10QSB
Source: SEC/Edgar
November 11, 2004
Form 8-K
Source: SEC/Edgar
October 27, 2004
Form 10KSB/A
Source: SEC/Edgar
October 27, 2004
Form 8-A12B
Source: SEC/Edgar
October 26, 2004
Form S-8
Source: SEC/Edgar
October 25, 2004
Form SC 13G
Source: SEC/Edgar
October 20, 2004
Form 8-K
Source: SEC/Edgar
October 14, 2004
Form 8-K
Source: SEC/Edgar
October 14, 2004
Form 10KSB
Source: SEC/Edgar
October 12, 2004
Form NTN 10K
Source: SEC/Edgar
September 29, 2004
Form 424B3
Source: SEC/Edgar
September 09, 2004
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.